FDA Announces EUA for OTC CLINITEST Rapid COVID-19 Self-Test
In a press release, the manufacturer, Siemens Healthineers, announced that the FDA granted Emergency Use Authorization (EUA) for the CLINITEST Rapid COVID-19 Antigen Self-Test, which will provide nationwide access to the new at-home or OTC self-test for COVID-19 for individuals, families, and businesses. The CLINITEST is an easy-to-use nasal swab test that is intended to aid in the swift detection of SARS-CoV-2. Read more.
|